Mendelian Randomisation: Concepts, Opportunities, Challenges, and Future Directions
References
- Holland PW. Statistics and causal inference. Journal of the American Statistical Association. 1986;81(396):945–960. DOI: 10.1080/01621459.1986.10478354
- Staiger DO, Stock JH.
Instrumental variables regression with weak instruments . National Bureau of Economic Research Cambridge, Mass., USA; 1994. DOI: 10.3386/t0151 - Katan MB. Apolipoprotein E isoforms, serum cholesterol, and cancer. The Lancet. 1986;327:507–508. DOI: 10.1016/S0140-6736(86)92972-7
- Davey Smith G, Ebrahim S. ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? International Journal of Epidemiology. 2003;32(1):1–22. DOI: 10.1093/ije/dyg070
- Schmidt AF, Finan C, Gordillo-Marañón M, Asselbergs FW, Freitag DF, Patel RS, et al. Genetic drug target validation using Mendelian randomisation. Nature Communications. 2020;11(1):
3255 . DOI: 10.1038/s41467-020-16969-0 - Schmidt AF, Hingorani AD, Finan C. Human genomics and drug development. Cold Spring Harb Perspect Med. 2022;12(2):
a039230 . DOI: 10.1101/cshperspect.a039230 - Burgess S, Thompson SG. Mendelian randomization: methods for using genetic variants in causal estimation. CRC Press; 2015.
- Yuan S, Lin A, He QQ, Burgess S, Larsson SC. Circulating interleukins in relation to coronary artery disease, atrial fibrillation and ischemic stroke and its subtypes: A two-sample Mendelian randomization study. Int J Cardiol. 2020;313:99–104. DOI: 10.1016/j.ijcard.2020.03.053
- Yuan S, Mason AM, Burgess S, Larsson SC. Genetic liability to insomnia in relation to cardiovascular diseases: a Mendelian randomisation study. Eur J Epidemiol. 2021;36(4):393–400. DOI: 10.1007/s10654-021-00737-5
- Wang L, Zhang X, Meng X, Koskeridis F, Georgiou A, Yu L, et al. Methodology in phenome-wide association studies: a systematic review. Journal of Medical Genetics. 2021;58(11):720–728. DOI: 10.1136/jmedgenet-2021-107696
- Zheng J, Haberland V, Baird D, Walker V, Haycock PC, Hurle MR, et al. Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases. Nature Genetics. 2020;52(10):1122–1131. DOI: 10.1038/s41588-020-0682-6
- Trubetskoy V, Pardiñas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022;604(7906):502–508. DOI: 10.1038/s41586-022-04434-5
- Campos AI, García-Marín LM, Byrne EM, Martin NG, Cuéllar-Partida G, Rentería ME. Insights into the aetiology of snoring from observational and genetic investigations in the UK Biobank. Nature Communications. 2020;11(1):
817 . DOI: 10.1038/s41467-020-14625-1 - Larsson SC, Burgess S. Appraising the causal role of smoking in multiple diseases: A systematic review and meta-analysis of Mendelian randomization studies. EBioMedicine. 2022;82:
104154 . DOI: 10.1016/j.ebiom.2022.104154 - Vithayathil M, Carter P, Kar S, Mason AM, Burgess S, Larsson SC. Body size and composition and risk of site-specific cancers in the UK Biobank and large international consortia: A mendelian randomisation study. PLoS Med. 2021;18(7):
e1003706 . DOI: 10.1371/journal.pmed.1003706 - Collaboration ERF. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. The Lancet. 2010;375(9709):132–140. DOI: 10.1016/S0140-6736(09)61717-7
- Danesh J, Pepys MB. C-reactive protein and coronary disease: is there a causal link? Am Heart Assoc. 2009;120(101):2036–2039. DOI: 10.1161/CIRCULATIONAHA.109.907212
- Collaboration CRPCHDG. Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ. 2011;15(342):
d548 . DOI: 10.1136/bmj.d548 - Zacho J, Tybjærg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG. Genetically elevated C-reactive protein and ischemic vascular disease. New England Journal of Medicine. 2008;359(18):1897–1908. DOI: 10.1056/NEJMoa0707402
- van der Bom JG, de Maat MP, Bots ML, Haverkate F, De Jong P, Hofman A, et al. Elevated plasma fibrinogen: cause or consequence of cardiovascular disease? Arteriosclerosis, Thrombosis, and Vascular Biology. 1998;18(4):621–625. DOI: 10.1161/01.ATV.18.4.621
- Porcu E, Rüeger S, Lepik K, Santoni FA, Reymond A, Kutalik Z. Mendelian randomization integrating GWAS and eQTL data reveals genetic determinants of complex and clinical traits. Nature Communications. 2019;10(1):
3300 . DOI: 10.1038/s41467-019-10936-0 - Khankari NK, Keaton JM, Walker VM, Lee KM, Shuey MM, Clarke SL, et al. Using Mendelian randomisation to identify opportunities for type 2 diabetes prevention by repurposing medications used for lipid management. EBioMedicine. 2022;80:
104038 . DOI: 10.1016/j.ebiom.2022.104038 - Richardson TG, Hemani G, Gaunt TR, Relton CL, Davey Smith G. A transcriptome-wide Mendelian randomization study to uncover tissue-dependent regulatory mechanisms across the human phenome. Nature Communications. 2020;11(1):
185 . DOI: 10.1038/s41467-019-13921-9 - Taylor K, Davey Smith G, Relton CL, Gaunt TR, Richardson TG. Prioritizing putative influential genes in cardiovascular disease susceptibility by applying tissue-specific Mendelian randomization. Genome Medicine. 2019;11:1–15. DOI: 10.1186/s13073-019-0613-2
- Xu X, Eales JM, Akbarov A, Guo H, Becker L, Talavera D, et al. Molecular insights into genome-wide association studies of chronic kidney disease-defining traits. Nature Communications. 2018;9(1):
4800 . DOI: 10.1038/s41467-018-07260-4 - Wu X, Jiang L, Qi H, Hu C, Jia X, Lin H, et al. Brain tissue-and cell type-specific eQTL Mendelian randomization reveals efficacy of FADS1 and FADS2 on cognitive function. Translational Psychiatry. 2024;14(1):
77 . DOI: 10.1038/s41398-024-02784-4 - Schmidt AF, Finan C, Gordillo-Marañón M, Asselbergs FW, Freitag DF, Patel RS, et al. Genetic drug target validation using Mendelian randomisation. Nature Communications. 2020;11(1):1–12. DOI: 10.1038/s41467-020-16969-0
- King EA, Davis JW, Degner JF. Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval. PLoS Genetics. 2019;15(12):
e1008489 . DOI: 10.1371/journal.pgen.1008489 - Ochoa D, Karim M, Ghoussaini M, Hulcoop DG, McDonagh EM, Dunham I. Human genetics evidence supports two-thirds of the 2021 FDA-approved drugs. Nat Rev Drug Discov. 2022;21(8):
551 . DOI: 10.1038/d41573-022-00120-3 - Plenge RM, Scolnick EM, Altshuler D. Validating therapeutic targets through human genetics. Nature Reviews Drug Discovery. 2013;12(8):581–594. DOI: 10.1038/nrd4051
- Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, Jensen MK, et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. The Lancet. 2012;380(9841):572–580. DOI: 10.1016/S0140-6736(12)60312-2
- Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, et al. Drug repurposing: progress, challenges and recommendations. Nature Reviews Drug Discovery. 2019;18(1):41–58. DOI: 10.1038/nrd.2018.168
- Huang J, Huffman JE, Huang Y, Do Valle I, Assimes TL, Raghavan S, et al. Genomics and phenomics of body mass index reveals a complex disease network. Nature Communications. 2022;13(1):
7973 . DOI: 10.1038/s41467-022-35553-2 - Burgess S, Davey Smith G, Davies NM, Dudbridge F, Gill D, Glymour MM, et al. Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res. 2019;4:
186 . DOI: 10.12688/wellcomeopenres.15555.1 - Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Statistics in Medicine. 2008;27(8):1133–1163. DOI: 10.1002/sim.3034
- Verbanck M, Chen C-Y, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nature Genetics. 2018;50(5):693–698. DOI: 10.1038/s41588-018-0099-7
- Sheehan NA, Meng S, Didelez V. Mendelian randomisation: a tool for assessing causality in observational epidemiology. Genetic Epidemiology. 2011;153–166. DOI: 10.1007/978-1-60327-416-6_12
- VanderWeele TJ, Tchetgen EJT, Cornelis M, Kraft P. Methodological challenges in mendelian randomization. Epidemiology. 2014;25(3):427–435. DOI: 10.1097/EDE.0000000000000081
- Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32(5):377–389. DOI: 10.1007/s10654-017-0255-x
- Swanson SA, Robins JM, Miller M, Hernán MA. Selecting on treatment: a pervasive form of bias in instrumental variable analyses. American Journal of Epidemiology. 2015;181(3):191–197. DOI: 10.1093/aje/kwu284
- Canan C, Lesko C, Lau B. Instrumental variable analyses and selection bias. Epidemiology. 2017;28(3):396–398. DOI: 10.1097/EDE.0000000000000639
- Vansteelandt S, Dukes O, Martinussen T. Survivor bias in Mendelian randomization analysis. Biostatistics. 2018;19(4):426–443. DOI: 10.1093/biostatistics/kxx050
- Burgess S, Butterworth A, Malarstig A, Thompson SG. Use of Mendelian randomisation to assess potential benefit of clinical intervention. BMJ. 2012;345:
e7325 . DOI: 10.1136/bmj.e7325 - Evangelou E, Warren HR, Mosen-Ansorena D, Mifsud B, Pazoki R, Gao H, et al. Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. Nature Genetics. 2018;50(10):1412–1425. DOI: 10.1038/s41588-018-0205-x
- Gill D, Dib MJ, Cronje HT, Karhunen V, Woolf B, Gagnon E, et al. Common pitfalls in drug target Mendelian randomization and how to avoid them. BMC Med. 2024;22(1):
473 . DOI: 10.1186/s12916-024-03700-9 - Magi R, Lindgren CM, Morris AP. Meta-analysis of sex-specific genome-wide association studies. Genetic Epidemiology. 2010;34(8):846–853. DOI: 10.1002/gepi.20540
- Bernabeu E, Canela-Xandri O, Rawlik K, Talenti A, Prendergast J, Tenesa A. Sex differences in genetic architecture in the UK Biobank. Nature Genetics. 2021;53(9):1283–1289. DOI: 10.1038/s41588-021-00912-0
- Shifman S, Johannesson M, Bronstein M, Chen SX, Collier DA, Craddock NJ, et al. Genome-wide association identifies a common variant in the reelin gene that increases the risk of schizophrenia only in women. PLoS Genetics. 2008;4(2):
e28 . DOI: 10.1371/journal.pgen.0040028 - Döring A, Gieger C, Mehta D, Gohlke H, Prokisch H, Coassin S, et al. SLC2 A9 influences uric acid concentrations with pronounced sex-specific effects. Nature Genetics. 2008;40(4):430–436. DOI: 10.1038/ng.107
- Lindgren CM, Heid IM, Randall JC, Lamina C, Steinthorsdottir V, Qi L, et al. Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genetics. 2009;5(6):
e1000508 . - Lumish HS, O’Reilly M, Reilly MP. Sex differences in genomic drivers of adipose distribution and related cardiometabolic disorders: opportunities for precision medicine. Arteriosclerosis, Thrombosis, and Vascular Biology. 2020;40(1):45–60. DOI: 10.1161/ATVBAHA.119.313154
- Aragam KG, Jiang T, Goel A, Kanoni S, Wolford BN, Atri DS, et al. Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants. Nature Genetics. 2022;54:1803–1815. DOI: 10.1038/s41588-022-01233-6
- Adlam D, Berrandou TE, Georges A, Nelson CP, Giannoulatou E, Henry J, et al. Genome-wide association meta-analysis of spontaneous coronary artery dissection identifies risk variants and genes related to artery integrity and tissue-mediated coagulation. Nature Genetics. 2023;55(6):964–972. DOI: 10.1038/s41588-023-01410-1
- Sakkers TR, Mokry M, Civelek M, Erdmann J, Pasterkamp G, Benavente ED, et al. Sex differences in the genetic and molecular mechanisms of coronary artery disease. Atherosclerosis. 2023; 384:
117279 . DOI: 10.1016/j.atherosclerosis.2023.117279 - Suhre K, Arnold M, Bhagwat AM, Cotton RJ, Engelke R, Raffler J, et al. Connecting genetic risk to disease end points through the human blood plasma proteome. Nature Communications. 2017;8(1):
14357 . DOI: 10.1038/ncomms14357 - Emilsson V, Ilkov M, Lamb JR, Finkel N, Gudmundsson EF, Pitts R, et al. Co-regulatory networks of human serum proteins link genetics to disease. Science. 2018;361(6404):769–773. DOI: 10.1126/science.aaq1327
- Sun BB, Maranville JC, Peters JE, Stacey D, Staley JR, Blackshaw J, et al. Genomic atlas of the human plasma proteome. Nature. 2018;558(7708):73–79. DOI: 10.1038/s41586-018-0175-2
- Benson MD, Yang Q, Ngo D, Zhu Y, Shen D, Farrell LA, et al. Genetic architecture of the cardiovascular risk proteome. Circulation. 2018;137(11):1158–1172. DOI: 10.1161/CIRCULATIONAHA.117.029536
- Yao C, Chen G, Song C, Keefe J, Mendelson M, Huan T, et al. Genome-wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular disease. Nature Communications. 2018;9(1):1–11. DOI: 10.1038/s41467-018-06231-z
- Zhernakova DV, Le TH, Kurilshikov A, Atanasovska B, Bonder MJ, Sanna S, et al. Individual variations in cardiovascular-disease-related protein levels are driven by genetics and gut microbiome. Nature Genetics. 2018;50(11):1524–1532. DOI: 10.1038/s41588-018-0224-7
- Richardson TG, Zheng J, Smith GD, Timpson NJ, Gaunt TR, Relton CL, et al. Mendelian randomization analysis identifies CpG sites as putative mediators for genetic influences on cardiovascular disease risk. The American Journal of Human Genetics. 2017;101(4):590–602. DOI: 10.1016/j.ajhg.2017.09.003
- Reay WR, Cairns MJ. Advancing the use of genome-wide association studies for drug repurposing. Nature Reviews Genetics. 2021;22(10):658–671. DOI: 10.1038/s41576-021-00387-z
- Mahajan A, Taliun D, Thurner M, Robertson NR, Torres JM, Rayner NW, et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nature Genetics. 2018;50(11):1505–1513. DOI: 10.1038/s41588-018-0241-6
- Chen J, Spracklen CN, Marenne G, Varshney A, Corbin LJ, Luan J, et al. The trans-ancestral genomic architecture of glycemic traits. Nature Genetics. 2021;53(6):840–860. DOI: 10.1038/s41588-021-00852-9
- Ntzani EE, Liberopoulos G, Manolio TA, Ioannidis JP. Consistency of genome-wide associations across major ancestral groups. Human Genetics. 2012;131:1057–1071. DOI: 10.1007/s00439-011-1124-4
- Peterson RE, Kuchenbaecker K, Walters RK, Chen C-Y, Popejoy AB, Periyasamy S, et al. Genome-wide association studies in ancestrally diverse populations: opportunities, methods, pitfalls, and recommendations. Cell. 2019;179(3):589–603. DOI: 10.1016/j.cell.2019.08.051
- Gurdasani D, Carstensen T, Fatumo S, Chen G, Franklin CS, Prado-Martinez J, et al. Uganda genome resource enables insights into population history and genomic discovery in Africa. Cell. 2019;179(4):984–1002. e36. DOI: 10.1016/j.cell.2019.10.004
- Assimes T, Tcheandjieu C, Zhu X, Hilliard A, Clarke S, Napolioni V, et al. A large-scale multi-ethnic genome-wide association study of coronary artery disease. Nature Medicine. 2022;28:1679–1692. DOI: 10.1038/s41591-022-01891-3
- Ishigaki K, Sakaue S, Terao C, Luo Y, Sonehara K, Yamaguchi K, et al. Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis. Nature Genetics. 2022;54(11):1640–1651. DOI: 10.1038/s41588-022-01213-w
- Pervjakova N, Moen G-H, Borges M-C, Ferreira T, Cook JP, Allard C, et al. Multi-ancestry genome-wide association study of gestational diabetes mellitus highlights genetic links with type 2 diabetes. Human Molecular Genetics. 2022;31(19):3377–3391. DOI: 10.1093/hmg/ddac050
- Oliva M, Muñoz-Aguirre M, Kim-Hellmuth S, Wucher V, Gewirtz AD, Cotter DJ, et al. The impact of sex on gene expression across human tissues. Science. 2020;369(6509):
eaba3066 . - Melé M, Ferreira PG, Reverter F, DeLuca DS, Monlong J, Sammeth M, et al. The human transcriptome across tissues and individuals. Science. 2015;348(6235):660–665. DOI: 10.1126/science.aaa0355
- Hartman RJ, Mokry M, Pasterkamp G, den Ruijter HM. Sex-dependent gene co-expression in the human body. Scientific Reports. 2021;11(1):
18758 . DOI: 10.1038/s41598-021-98059-9
DOI: https://doi.org/10.5334/gh.1438 | Journal eISSN: 2211-8179
Language: English
Submitted on: May 12, 2025
Accepted on: May 27, 2025
Published on: Jun 17, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2025 Sophie C. de Ruiter, Lena Tschiderer, Diederick E. Grobbee, Peter Willeit, Hester M. den Ruijter, A. Floriaan Schmidt, Sanne A. E. Peters, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.